Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.

Roland ME, Barin B, Huprikar S, Murphy B, Hanto DW, Blumberg E, Olthoff K, Simon D, Hardy WD, Beatty G, Stock PG; HIVTR Study Team.

AIDS. 2016 Jan 28;30(3):435-44. doi: 10.1097/QAD.0000000000000934.

2.

Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST).

Kasiske BL, Israni AK, Snyder JJ, Camarena A; COST Investigators.

Am J Kidney Dis. 2011 Jun;57(6):908-16. doi: 10.1053/j.ajkd.2011.01.020. Epub 2011 Mar 15.

3.

Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.

Pescovitz MD, Nezakatgoo N, Lorber MI, Nashan B, Tedesco-Silva H Jr, Kasiske BL, de la Cruz FJ, Russ G, Campistol J, Keown PA; International Sirolimus Study Group.

Transplantation. 2009 Oct 27;88(8):1010-8. doi: 10.1097/TP.0b013e3181b9d0da.

PMID:
19855247
4.

Pancreas transplant and incidental Meckel's diverticulum: not always a straightforward decision.

Light TD, Light JA.

Clin Transplant. 2009 Sep-Oct;23(5):765-8. doi: 10.1111/j.1399-0012.2009.01029.x. Epub 2009 Jun 26.

PMID:
19563483
5.

The Washington, D.C. experience with uncontrolled donation after circulatory determination of death: promises and pitfalls.

Light JA.

J Law Med Ethics. 2008 Winter;36(4):735-40, 610. doi: 10.1111/j.1748-720X.2008.00332.x.

PMID:
19094001
6.

Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant.

Alexander JW, Goodman HR, Succop P, Light JA, Kuo PC, Moser AB, James JH, Woodle ES.

Exp Clin Transplant. 2008 Jun;6(2):118-26.

7.

Pancreas transplant and incidental meckel diverticulum: not always a straightforward decision.

Light TD, Light JA.

South Med J. 2008 Jun;101(6):665-6. doi: 10.1097/SMJ.0b013e318172f637. No abstract available.

PMID:
18528227
8.

Clinically significant proteinuria following the administration of sirolimus to renal transplant recipients.

Perlman AS, Kim EH, Kallakury B, Light JA, Moore J Jr.

Drug Metab Lett. 2007 Dec;1(4):267-71.

PMID:
19356053
9.

Trends in donation after cardiac death.

Light JA, Cecka JM.

Clin Transpl. 2005:235-45.

PMID:
17424743
10.

Of ends and means.

Kirk AD, Light JA.

Am J Transplant. 2006 Oct;6(10):2228-9. Epub 2006 Aug 21. No abstract available.

11.

Cardiac surgery in renal transplant recipients: experience from Washington Hospital Center.

Zhang L, Garcia JM, Hill PC, Haile E, Light JA, Corso PJ.

Ann Thorac Surg. 2006 Apr;81(4):1379-84.

PMID:
16564276
12.

Bilateral laparoscopic radical nephrectomy for renal tumors in patients with acquired cystic kidney disease.

Ghasemian SR, Pedraza R, Sasaki TA, Light JA, Patel SV.

J Laparoendosc Adv Surg Tech A. 2005 Dec;15(6):606-10.

PMID:
16366867
14.
15.

Stump transureteroureterostomy in en bloc kidney transplantation.

Ghasemian R, Bugarin E, Light JA.

Transplantation. 2005 Mar 27;79(6):743. No abstract available.

PMID:
15785391
16.

Human renal allograft rejection despite the absence of allogeneic passenger leukocytes.

Preston EH, Light JA, Kampen RL, Kirk AD.

Am J Transplant. 2004 Feb;4(2):283-5.

17.

Acute renal transplant rejection possibly related to herbal medications.

Light TD, Light JA.

Am J Transplant. 2003 Dec;3(12):1608-9.

18.
19.

Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation.

Light JA, Sasaki TM, Ghasemian R, Barhyte DY, Fowlkes DL.

Clin Transplant. 2002;16 Suppl 7:30-3.

PMID:
12372041
20.

Primary cutaneous fungal infections in solid organ transplantation: a case series.

Miele PS, Levy CS, Smith MA, Dugan EM, Cooke RH, Light JA, Lucey DR.

Am J Transplant. 2002 Aug;2(7):678-83.

Supplemental Content

Loading ...
Support Center